After four years of working with the National Institute for Health and Care Excellence (NICE) we are delighted to announce that a Guideline on the Diagnosis and Maintenance of Pernicious Anaemia was commissioned by the institution in August of this year.
This is a major leap forward not only for this society whose main aim has always been to get the way in which Pernicious Anaemia is diagnosed and treated thoroughly reviewed. It also promises to bring to an end the problem with patients not getting diagnosed accurately and quickly and should lead to better treatment.
NICE accepted our call for a Guideline in late 2018, but it has sat in the in-tray of the organisation since then. However, we believe that the political pressure that was brought to bear on the institution and other health bodies has led NICE to have started the process of thoroughly reviewing how Pernicious Anaemia is both diagnosed and treated.
Executive Chairman Martyn Hooper:
“I would first of all like to thank all of our members who took the trouble to contact their elected representatives and ask him or her to ask NICE to take the next step and commission a review”
“I can’t say for certain but I’m sure that the political pressure helped to raise awareness of the urgency of developing a Guideline”
The whole process will take around three years to complete. The first part of the Guideline Development will be to ask all interested organisations to register as a Stakeholder. This society has already registered as have most if not all of the organisations that our research partners belong to.
Dr. Paul Chrisp, the Director of Guidelines at NICE, has welcomed the work of this society;
“We are grateful to the PA Society for making us aware of the on-going issues with the diagnosis and treatment of Pernicious Anaemia. The charity is an important stakeholder for us as we develop guidance in this important area.”
We have already helped NICE with their revised Clinical Knowledge Summary in response to the Covid-19 pandemic in the Spring and look forward to being part of the process of producing a Guideline specifically on Pernicious Anaemia.
Individuals are not eligible to register as stakeholders as themselves as only people representing organisations can become part of the process. The Pernicious Anaemia Society has already registered and Martyn Hooper, along with one other person will be our representatives. If you are a representative of an organisation that would like to become a stakeholder please go here to register.
To see a list of stakeholders already registered please go here. The list of stakeholders will be updated regularly.
The Process of guideline development
Now that Pernicious Anaemia has been chosen as the topic for a Guideline the next stage will be to produce a SCOPE. The Scope will outline why there is a need for the guideline, the areas the guideline will and will not cover and what it intends to achieve.
The Scoping Workshop will take place on the 18th November and a draft Scope will be produced for stakeholders to comment on during the Draft Scope Consultation between the 18th December 2020 and the 20th January 2021.
When the Scope is agreed on the next process will be to draw up a series of Review Questions. These questions will be the basis of the evidence search and the next stage is a literature search which will include additional materials from this society. This is where we will be able to put your concerns about diagnosis and treatment into the process. An Evidence Review is then produced and the Costs are considered (we have already proved that the poor diagnosis costs over £8million in wasted GP consultation in England alone) before all of the evidence is put to a committee made up of clinicians, practitioners, professionals, care providers, commissioners, those who use services and family members or carers. This is where we will be actively providing the committee with evidence of the patient experience.
The committee will then produce a Draft Guideline which will be sent to all Stakeholders who will be invited to comment.
The comments will then be considered before the Guidance Executive produce a final version of the Guideline that is then signed off and made available.
Members of the Guidance Executive can be found here.
The date for publication has been set as the 23rd March, 2023.
As you can see, there is still an awful lot that we have to do to ensure that your views and concerns are considered by the decision makers. We are confident that by making our views known in a professional manner we will bring about changes that will have a significant impact on the way in which patients with Pernicious Anaemia are diagnosed and treated. We’ll keep you informed of the Guideline’s process.